Atorvastatin increases endoglin, SMAD2, phospohorylated SMAD2/3 and eNOS expression in ApoE/LDLR double knockout mice

Abstract

In this study we aimed to elucidate whether endoglin is co-expressed with SMAD2, phospohorylated SMAD2/3 and eNOS in vivo in atherosclerotic lesions in ApoE/LDLR double knockout mice, and whether the expression of this proteins is affected by atorvastatin treatment.

Keywords

• endoglin
• SMAD2
• phosphorylated SMAD2/3
• eNOS
• atorvastatin
• ApoE/LDLR double knockout mice